We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Protein Sciences

News List

Sanofi completes acquisition of Protein Sciences for $750m pharmaceutical-technology
August 30, 2017
French pharmaceutical company Sanofi has completed the acquisition of US-based vaccine development firm Protein Sciences for $750m.
Sanofi gets a flu vaccines booster with $650M-plus Protein Sciences buy fiercepharma
July 14, 2017
Twice over the last year, Sanofi has come up short in high-stakes attempts at top M&A prospects. Now, the drugmaker has finally bagged an acquisition, though not on the scale of its runs for Medivation or Actelion.
Sanofi to acquire Protein Sciences cphi-online
July 13, 2017
Acquisition adds recombinant-based influenza vaccine to Sanofi Pasteur's portfolio.
Sanofi agrees to buy Protein Sciences for $750m pharmaceutical-technology
July 13, 2017
Sanofi has entered an agreement to acquire Protein Sciences, a privately held vaccines biotechnology company based in Meriden, Connecticut, US.